Regulatory Filings • Jul 10, 2023
Regulatory Filings
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } .au{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.au{}p.n,li.n,div.n{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}span.bj{font-size:11.0pt;font-family: "Calibri","sans-serif";color:black}p.bk{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align: center}span.bl{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.bm{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align: center}span.be{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}p.bn{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:center}p.bo{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify} span.bp{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}p.bq{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}table.br{width:451.3pt;margin-left:-5.65pt;border-collapse:collapse}td.ay{width:223.4pt;padding:0cm 5.4pt 0cm 5.4pt}p.bs{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}span.ba{color:#212721}td.aw{width:206.3pt;padding:0cm 5.4pt 0cm 5.4pt}p.bt{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt; text-align:right;line-height:normal} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .au{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/ ![]()
RNS Number : 4094F
Inspiration Healthcare Group PLC
10 July 2023
10 July 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", "the Group" or the "Company")
Change of registered office
Inspiration Healthcare Group plc (AIM: IHC), announces that it has changed the Company's registered office to Unit 7/8 Commerce Park, Commerce Way, Croydon, CR0 4YL with immediate effect.
For further information please contact:
| Inspiration Healthcare Group plc | Tel: +44 (0)330 175 0000 |
| Neil Campbell, Chief Executive Officer Alan Olby, Chief Financial Officer |
|
| Liberum (Nominated Adviser & Broker) | Tel: +44 (0)20 3100 2000 |
| Phil Walker, Richard Lindley, William Hall, Will King | |
| Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or [email protected] |
| Anna Dunphy | Mob: +44 (0) 7876 741 001 |
| Stephanie Cuthbert | Mob: +44 (0) 7796 794 663 |
| Louis Ashe-Jepson | Mob: +44 (0) 7747 515 393 |
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.
Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.
With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CRODDLFBXDLFBBX
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.